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Abstract 
Background: The purpose of this review was to investigate the efficacy and safety of yoga 
interventions in treating patients with major depressive disorder. 
Methods: MEDLINE, Scopus, and the Cochrane Library were screened through December 
2016. Randomized controlled trials (RCTs) comparing yoga to inactive or active comparators 
in patients with major depressive disorder were eligible. Primary outcomes included 
remission rates and severity of depression. Anxiety and adverse events were secondary 
outcomes. Risk of bias was assessed using the Cochrane tool. 
Results: Seven RCTs with 240 participants were included. Risk of bias was unclear for most 
RCTs. Compared to aerobic exercise, no short- or medium-term group differences in 
depression severity was found. Higher short-term depression severity was found for yoga 
compared to electro-convulsive therapy; remission rates did not differ between groups. No 
short-term group differences occurred when yoga was compared to antidepressant 
medication. Conflicting evidence was found when yoga was compared to attention-control 
interventions, or when yoga as an add-on to antidepressant medication was compared to 
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medication alone. Only two RCTs assessed adverse events and reported that no treatment-
related adverse events were reported. 
Limitations: Few RCTs with low sample size. 
Conclusions: This review found some evidence for positive effects beyond placebo and 
comparable effects compared to evidence-based interventions. However, methodological 
problems and the unclear risk-benefit ratio preclude definitive recommendations for or 
against yoga as an adjunct treatment for major depressive disorder. Larger and adequately 
powered RCTs using non-inferiority designs are needed. 
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Depression is one of the most prevalent psychiatric disorders as it affects 25% of women and 
12% of men during their lifetime and increases the psychological strain for the affected 
person (Kessler et al., 2003; Moussavi et al., 2007; Rubio et al., 2011). Moreover, depression 
is characterized by a high comorbidity with several chronic conditions like addictions (Lai et 
al., 2015), neurodegenerative diseases (Herbert and Lucassen, 2016; Riccelli et al., 2016) or 
different psychiatric diseases (Azar et al., 2016; Chechko et al., 2016; Chen et al., 2016; 
Ronconi et al., 2015) can be observed. Depression is projected as one of the leading causes 
of disability worldwide (Global Burden of Disease Study Collaborators, 2015). 
The most commonly used treatments for depression are pharmacological (antidepressant) 
therapy, psychotherapy, or a combination of both. Both therapies have been previously 
shown to be effective for treating depression (Leichsenring et al., 2016). But recent reviews 
found high dropout rates, low remission rates, and high placebo responses for these 
therapies (Mathew and Charney, 2009; Pigott et al., 2010; Rief et al., 2009; Turner et al., 
2008); and complementary and alternative therapies can be a promising adjunct in the 
treatment of depression (Ravindran et al., 2016).  
Yoga, a combination of movement, mindfulness and relaxation, is a traditional Indian 
philosophical and spiritual practice originated around 5000 years ago (Iyengar, 1966). 
Modern yoga forms based on Hatha yoga, which are commonly used in the western world, 
are mostly associated with physical postures (asanas), breathing techniques (pranayama), 
and meditation (dyana) (Yogi Hari, 2006). Yoga has become a popular means to promote 
physical and mental well-being (Cramer et al., 2016a; Cramer, 2015). The efficacy of yoga in 
improving comorbid mental symptoms could be shown for different health conditions such as 
pain (Chang et al., 2016; Kim, 2016), cancer (Sharma et al., 2016b), psychiatric diseases 
(Cramer et al., 2013b; Hofmann et al., 2016; Pascoe and Bauer, 2015) and other chronical 
diseases (Desveaux et al., 2015; Schumann et al., 2016). Specifically for depression, a 
recent review could show that yoga interventions can be an effective treatment option 
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(Cramer et al., 2013c). However, this review included a variety of depressive disorders as 
well as individuals without a formal diagnosis of depression, rendering conclusions on yoga’s 
efficacy in specific disorders difficult. 
Due to the complex treatment situation, further information about effectiveness of yoga 
therapy in treating different levels of depression is needed. The purpose of this review is to 
investigate the efficacy and safety of yoga interventions in treating patients with major 
depressive disorder.  
Methods 
This review was conducted and reported in accordance with the Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA) guidelines (Moher et al., 2009) as well 
as the recommendations of the Cochrane Collaboration (Higgins and Green, 2008). 
Eligibility criteria 
Types of studies 
Eligible study types included randomized controlled trials (RCTs), cluster-randomized trials 
and randomized cross-over studies. No language restrictions were applied. 
Types of participants 
Studies that included participants with a DSM-IV or DSM-V diagnosis of major depressive 
disorder were eligible. It was post-hoc decided to also include studies in which the majority of 
participants (≥75%) were diagnosed with major depressive disorder and the remaining 
participants with other depressive disorders. 
Types of interventions 
Studies were eligible if they compared yoga with no specific treatment, pharmacological or 
non-pharmacological interventions. No restrictions were made regarding yoga tradition, 
length, frequency, or duration of the program. Co-interventions were allowed as long as 
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participants in all intervention groups received the same co-interventions. Head-to-head 
comparisons of different types of yoga without a non-yoga control group were excluded. 
Types of outcome measures 
To be eligible, studies had to assess at least one of the main outcome measures: 
1. Remission rates, i.e. the number of participants who obtained remission 
2. Severity of depression measured by self-rating scales or by clinician-rated scales 
Secondary outcome measures included: 
1. Severity of anxiety measured by self-rating scales or by clinician-rated scales 
2. Serious adverse events (including suicide and suicide attempts) 
3. Non-serious adverse events 
Adverse events resulting in 1) death, 2) life-threatening situations, 3) hospitalization, 4) 
disability or permanent damage, 5) congenital anomaly/birth defect, or 6) the need for 
medical or surgical intervention to prevent outcomes 1–5 were defined as serious. All other 
adverse events were regarded as non-serious (US Food and Drug Administration, 2016). 
Search methods 
Medline/PubMed, Scopus, and the Cochrane Central Register of Controlled Trials (Central) 
were searched from their inception through December 06, 2016. The literature search was 
constructed around search terms for “yoga” and search terms for “major depressive 
disorders”. The complete search strategy for Pubmed/Medline was (“Depression”[Mesh] OR 
“Depressive Disorder”[Mesh] OR depression[Title/Abstract] OR depressive[Title/ Abstract]) 
AND (“Yoga”[Mesh] OR yoga[Title/Abstract] OR yogic[Title/Abstract]). The search strategy 
was adapted for each database as necessary. 
In addition, our own extensive database (Cramer et al., 2014), reference lists of identified 
original articles or reviews and the tables of contents of the International Journal of Yoga 
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Therapy, the Journal of Yoga & Physical Therapy, and the International Scientific Yoga 
Journal SENSE were searched manually. 
Two review authors independently screened abstracts identified during literature search were 
screened and read potentially eligible articles in full to determine whether they met the 
eligibility criteria. 
Data extraction and management 
Two review authors independently extracted data on participants (e.g. diagnostic criteria, 
age, gender, race), interventions (e.g. yoga type, components, duration), control 
interventions (e.g. type, duration), outcomes (e.g. outcome measures, assessment time 
points), and results using an a priori developed data extraction form. Discrepancies were 
discussed with a third review author until consensus was reached. 
Risk of bias in individual studies 
Two review authors independently assessed risk of bias on the following domains: selection 
bias (random sequence generation, allocation concealment), performance bias (blinding of 
participants and personnel), detection bias (blinding of outcome assessment), attrition bias 
(incomplete outcome data), reporting bias (selective reporting), and other bias using the 
Cochrane risk of bias tool (Higgins and Green, 2008). All domains were scored as 1) low risk 
of bias, 2) unclear, or 3) high risk of bias. Discrepancies were discussed with a third review 
author until consensus was reached. 
Results 
Literature search 
Nine hundred ninety-seven non-duplicate records were retrieved by literature search; 979 of 
which were excluded because they were not randomized, did not include participants with 
major depression and/or did not include yoga as an intervention. Seventeen full-texts were 
assessed for eligibility (Butler et al., 2008; Field et al., 2013a, b; Field et al., 2012; 
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Gangadhar et al., 2013; Kinser et al., 2013; Kinser et al., 2014; Lavretsky et al., 2013; 
Naveen et al., 2013; Naveen et al., 2016; Rohini et al., 2000; Thirthalli et al., 2013; 
Uebelacker et al., 2016); and 8 articles were excluded because they were either not 
randomized (Naveen et al., 2013; Naveen et al., 2016; Thirthalli et al., 2013), no non-yoga 
control group was used (Rohini et al., 2000), the included participants were not diagnosed 
with a depressive disorder (Lavretsky et al., 2013), they were diagnosed with a depressive 
disorder but less than 75% with major depressive disorder (Butler et al., 2008), or it was 
unclear with what depressive disorder the participants were diagnosed (Field et al., 2013a, b; 
Field et al., 2012). One additional full-text was excluded because it was originally planned as 
an RCT but later changed to a non-randomized controlled study design and only a minority of 
participants actually were randomized (Gangadhar et al., 2013). Eight articles reporting 
seven RCTs on yoga for participants with major depressive disorder, encompassing 240 
participants, were finally included in the analysis (Figure 1) (Janakiramaiah et al., 2000; 
Kinser et al., 2013; Kinser et al., 2014; Sarubin et al., 2014; Schuver and Lewis, 2016; 
Sharma et al., 2016a; Sharma et al., 2005; Uebelacker et al., 2016). 
Characteristics of the included studies 
The characteristics of the included studies are shown in Table 1. 
Setting and participant characteristics 
Seven RCTs with a total of 240 participants were included. Sample size ranged from 20 to 53 
with a median size of 30 participants. Two RCTs originated from India (Janakiramaiah et al., 
2000; Sharma et al., 2005), four from the USA (Kinser et al., 2013; Kinser et al., 2014; 
Schuver and Lewis, 2016; Sharma et al., 2016a; Uebelacker et al., 2016), and one from 
Germany (Sarubin et al., 2014). Participants were recruited from psychiatric inpatient 
(Sharma et al., 2005), psychiatric (Janakiramaiah et al., 2000; Sharma et al., 2016a), 
gynecological (Uebelacker et al., 2016), or other outpatient services (Kinser et al., 2013; 
Kinser et al., 2014), and through online advertisements (Schuver and Lewis, 2016). One 
8 
 
RCT did not report methods of recruitment (Sarubin et al., 2014). All seven RCTs used DSM-
IV diagnostic criteria; all but two included exclusively patients with major depressive disorder; 
and patients in all RCTs were in a current major depressive episode. Participants’ mean age 
ranged from 28.4 years to 43.4 years with a median age of 38.7 years. Between 28.3% and 
100.0% (median: 72%) of participants in each study were female. Only three studies reported 
on ethnicity; between 63% and 100% (median: 93.5%) were of Caucasian ethnicity (Kinser et 
al., 2013; Kinser et al., 2014; Schuver and Lewis, 2016; Uebelacker et al., 2016). 
Intervention characteristics  
Five RCTs used yoga interventions which included yoga postures, breathing exercises, 
meditation, and relaxation (Kinser et al., 2013; Kinser et al., 2014; Sarubin et al., 2014; 
Schuver and Lewis, 2016; Sharma et al., 2016a; Uebelacker et al., 2016). Two of those 
RCTs utilized Hatha yoga without specifying a yoga style (Kinser et al., 2013; Kinser et al., 
2014; Sarubin et al., 2014), one used mindfulness-yoga, i.e. combined the DVD-delivered 
LifeForce yoga program with telephone counseling based on the Mindfulness-Based Stress 
Reduction program (Schuver and Lewis, 2016), one used a prenatal yoga program 
(Uebelacker et al., 2016) and one used Sudarshan Kriya Yoga breathing exercises combined 
with yoga postures and meditation (Sharma et al., 2016a). The other two RCTs used yoga 
interventions without physical postures that encompassed meditation either alone, i.e. Sahaj 
yoga meditation (Sharma et al., 2005), or in combination with breathing exercises, i.e. 
Sudarshan Kriya Yoga (Janakiramaiah et al., 2000). The yoga intervention was delivered by 
yoga teachers (Janakiramaiah et al., 2000; Kinser et al., 2013; Kinser et al., 2014; Sharma et 
al., 2005; Uebelacker et al., 2016), physical therapists (Sarubin et al., 2014) or unsupervised 
using a DVD with discussion of the yoga experience during weekly telephone counseling 
(counselors’ qualification not reported) (Schuver and Lewis, 2016). Interventions were 
delivered in group setting except for one RCT using unsupervised yoga (Schuver and Lewis, 
2016); for three further RCTs it was unclear whether group settings or individual interventions 
were used (Janakiramaiah et al., 2000, Sarubin et al., 2014, Sharma 2005). The 
9 
 
interventions were delivered for 5 to 12 weeks (median: 8 weeks); frequency ranged from 1 
to 6 sessions per week with a median of 2 session per week; and the sessions’ duration 
ranged from 30 to 210 minutes (median 75 minutes) per session. Overall, between 120 and 
1890 minutes of contact time with the therapist were offered (median 675 minutes). 
Two RCT used an inactive control group that did not receive any specific intervention 
besides standard care (see below) (Sarubin et al., 2014; Sharma et al., 2016a); the 
remaining five RCTs used active control groups. Control interventions consisted of an 
attention-control intervention of the same time and therapists’ attention but without the 
assumed therapeutic component (Kinser et al., 2013; Kinser et al., 2014; Sharma et al., 
2005; Uebelacker et al., 2016), a home-based walking intervention with additional telephone 
counseling of the same intensity as the yoga intervention (Schuver and Lewis, 2016), electro-
convulsive therapy three times per week over a period of 4 weeks (Janakiramaiah et al., 
2000), and the tricyclic antidepressant Imipramin once daily 150 mg over a period of 4 weeks 
(Janakiramaiah et al., 2000). 
One RCT precluded any additional antidepressant medication (a tricyclic antidepressant was 
used as a control intervention) (Janakiramaiah et al., 2000); four RCTs allowed individual 
antidepressant medication (Kinser et al., 2013; Kinser et al., 2014; Schuver and Lewis, 2016; 
Sharma et al., 2005; Uebelacker et al., 2016). Participants in one RCT were treated with 
either atypical antipsychotic drugs with antidepressant properties or SSRIs in addition to the 
allocated study treatment (Sarubin et al., 2014), participants in another RCT were on a stable 
dose of any antidepressant medication in addition to the allocated study treatment (Sharma 
et al., 2016a). 
Outcome measures 
Outcomes were assessed immediately after the end of the intervention in all RCTs. One RCT 
additionally assessed outcomes at one-month follow-up (Schuver and Lewis, 2016), and one 
assessed outcomes at one-year follow-up (Kinser et al., 2013; Kinser et al., 2014).  All RCTs 
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assessed severity of depression using clinician-assessed instruments such as the Hamilton 
Rating Scale for Depression (Janakiramaiah et al., 2000; Sarubin et al., 2014; Sharma et al., 
2016a; Sharma et al., 2005), or the Quick Inventory of Depressive Symptoms-Clinician 
Rating (Uebelacker et al., 2016 ), or patient-reported measures such as the Beck Depression 
Inventory (Janakiramaiah et al., 2000; Schuver and Lewis, 2016; Sharma et al., 2016a), the 
Edinburgh Postnatal Depression Scale (Uebelacker et al., 2016), or the Patient Health 
Questionnaire (Kinser et al., 2013; Kinser et al., 2014). Three RCTs assessed remission 
rates defined as the number of participants with a depression severity below a specific 
threshold (Janakiramaiah et al., 2000; Sharma et al., 2016a; Sharma et al., 2005). Two 
further RCT assessed responder rates defined as the number of participants with a reduction 
of depression severity of more than 50% (Sarubin et al., 2014; Sharma et al., 2016a). Two 
RCT assessed severity of comorbid anxiety using the physician-assessed Hamilton Rating 
Scale for Anxiety (Sharma et al., 2005) or the Beck Anxiety Inventory (Sharma et al., 2016a). 
None of the included RCTs assessed the total frequency of serious adverse events or non-
serious adverse events but two RCTs assessed treatment-related adverse events (Sharma 
et al., 2016a; Uebelacker et al., 2016). 
Risk of bias in individual studies  
Risk of bias in individual studies is shown in table 2. Risk of selection bias generally was 
unclear; only three RCTs reported adequate methods of random sequence generation 
(Kinser et al., 2013; Kinser et al., 2014; Schuver and Lewis, 2016; Sharma et al., 2016a); and 
no RCT reported on allocation concealment. Only three RCTs reported on blinding and two 
reported adequate blinding of outcome assessment but all reported lack of blinding of study 
participants (Kinser et al., 2013; Kinser et al., 2014; Schuver and Lewis, 2016; Sharma et al., 
2016a). Only one RCT used an intention-to-treat analysis (Sharma et al., 2016a), but two 
further RCTs had a low attrition rate (Janakiramaiah et al., 2000; Schuver and Lewis, 2016). 
Risk of reporting bias and other bias were low in all but three RCTs (Sharma et al., 2016a; 




Yoga vs. attention control 
Compared to an attention-control intervention, positive short-term effects of yoga on 
physician-assessed severity of depression and anxiety were found in one of three RCTs. 
Further group differences occurred in this RCT regarding remission rates with 47% of 
participants in the yoga group being in remission after 8 weeks of intervention compared to 
13% in the attention-control group (Sharma et al., 2005). Another RCT found positive long-
term effects of yoga on patient-reported severity of depression but only 7 and 2 participants 
were included in the yoga and control group, respectively, for this analysis (Kinser et al., 
2013; Kinser et al., 2014). Risk of selection and detection bias was mixed. 
Yoga vs. exercise 
When yoga was compared to an intensity- and attention-matched walking intervention, no 
groups differences in severity of depression was found at the end of the 12-week intervention 
period or at one-month follow-up (Schuver and Lewis, 2016). Risk of selection bias was 
mixed, however risk of detection bias was low. 
Yoga vs. electro-convulsive therapy 
After four weeks of treatment, significantly higher severity of depression was found for 
participants in the yoga group compared to participants receiving electro-convulsive therapy. 
Remission rates did not differ significantly between groups although 93% of participants 
receiving electro-convulsive therapy remitted compared to 67% of participants in the yoga 
group (Janakiramaiah et al., 2000). Risk of selection and detection bias were unclear. 
Yoga vs. medication 
Comparing yoga to antidepressant medication, no group difference in depression severity 
was found. After 4 weeks of intervention, 67% of participants in the yoga group were in 
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remission compared to 73% in the medication group (Janakiramaiah et al., 2000). Risk of 
selection and detection bias were unclear. 
When yoga as an add-on to antidepressant medication was compared to medication alone, 
one of two RCTs found positive effects of yoga on depression severity (Sharma et al., 
2016a), while the other found no group difference (Sarubin et al., 2014). Responder rates did 
not differ between groups in both studies. One RCT reported 59% responders in the yoga 
group and 58% responders in the control group (Sarubin et al., 2014), the second RCT found 
8.3% and 46.2% responders in the yoga and control group, respectively, and 8.3% and 
30.8% remitters, respectively (Sharma et al., 2016a). None of these group differences was 
significant. One RCT assessed safety-related data and reported that no treatment-emergent 
adverse events were reported.  Risk of selection and detection bias was unclear in one of the 
RCTs (Sarubin et al., 2014); risk of selection bias was mixed and risk of selection bias was 
low in the other one (Sharma et al., 2016a). 
Discussion 
Summary of evidence  
In this systematic review of seven RCTs, comparable effects were found for yoga compared 
to exercise and medication. Electro-convulsive therapy induced stronger antidepressant 
effects than yoga. Conflicting evidence was found when yoga was compared to attention-
control interventions or when yoga was used as an add-on to antidepressant medication was 
compared to medication alone. The safety of the intervention remained largely unclear.  
Agreements with prior systematic reviews 
To the best of our knowledge, this is the first systematic review specifically investigating yoga 
practice in patients diagnosed with major depressive disorder. However, the findings are 
partly in line with prior systematic reviews on yoga across the depression spectrum (Cramer 
et al., 2013c; Pilkington et al., 2005). In an early review, Pilkington et al. concluded that yoga 
might have potential beneficial effects for patients with depressive disorders (Pilkington et al., 
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2005). In line with the current review, the authors saw their conclusions limited by the high 
risk of bias and the lack of safety data in the included trials. A further review concluded that 
yoga as a treatment for depression is based on plausible mechanisms and can augment 
current depression treatment strategies (Uebelacker et al., 2010). A more recent review and 
meta-analysis found positive effects of yoga for depressive disorders but only when 
compared to relaxation but not when compared to usual care (Cramer et al., 2013c). In 
contrast to the current review, yoga was superior to aerobic exercise; however this finding 
was limited to individuals with elevated levels of depression without a formal psychiatric 
diagnosis. Again, high risk of bias and lack of safety data limited the expressiveness of the 
findings. It should be noted, that the prior reviews included only one (Pilkington et al., 2005) 
or two (Cramer et al., 2013c) of the RCT that were included in the current review. Finally, a 
recent overview of systematic reviews focusing on mental health professionals concluded 
that there is growing evidence supporting the use of yoga for the management of depression 
but that further high-quality research is needed (Butterfield et al., 2017). 
External and internal validity 
The RCTs included patients from North America, Europe and Asia. All patients were 
diagnosed by DSM-IV criteria. Given that the removal of the bereavement exclusion was the 
main change for a diagnosis of major depressive disorder from DSM-IV to DSM-V, all 
patients in all included studies would most likely still be diagnosed with the same disorder 
(American Psychiatric Association, 2013). The findings of the included RCTs can however 
not be applied to patients suffering from depressive symptoms lasting less than two months 
following the death of a loved one. The applicability of the findings is further limited by the 
low number of included RCTs and their unclear to high risk of bias. 
Strengths and weaknesses 
Strengths of this review include the comprehensive literature search and the assessment of 
applicability of the results (Gartlehner, 2008). The primary limitation of this review is the 
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deficiency of eligible studies, resulting in a rather low overall sample size. Specifically, most 
comparisons (yoga vs. exercise, electro-convulsive therapy, or medication or yoga as add-on 
to medication) were based on only one RCT each. The applicability of the findings was 
limited and safety was not adequately reported in any RCT. Due to the low number of eligible 
trials and their heterogeneity regarding participants, interventions, and control groups, no 
meta-analysis could be performed. 
Implications for further research 
More RCTs on yoga specifically for major depressive disorders are needed to conclusively 
judge its potential in this population. Authors of prospect research should improve the 
reporting of yoga trials and adhere to standard reporting guidelines (e.g. CONSORT) (Schulz 
et al., 2010). Further RCTs should ensure rigorous methodology including a-priori sample 
size calculations to prevent negative results due to lack of power. They should further apply 
adequate methods of randomization, allocation concealment, intention-to-treat analysis, and 
blinding of at least outcome assessors (Schulz et al., 2010). 
Yoga RCTs should also improve reporting of safety. While no evidence for serious yoga-
associated adverse events or an accumulation of adverse events has been found in yoga 
RCTs reporting on safety (Cramer et al., 2015), there clearly is a lack of sufficient reporting of 
yoga-associated adverse events. Yoga has also been occasionally associated with serious 
adverse events, and patients with psychiatric disorders might be particularly prone to 
symptom aggravation due to yoga practice (Cramer et al., 2013a). About five percent of yoga 
practitioners diagnosed with bipolar disorder have e.g. reported yoga-associated 
aggravations of their depressive symptoms (Uebelacker et al., 2014). This should be closely 
monitored in future RCTs. 
While this review found comparable effects of yoga compared to other evidence-based 
interventions (Gelenberg et al., 2010), this finding might mainly reflect a lack of power due to 
the small number of eligible RCTs and their relatively low sample size; none of the RCTs 
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comparing yoga to an active intervention included more than 20 patients per study arm. 
Larger and adequately powered RCTs using non-inferiority designs are needed before the 
comparative effectiveness of yoga compared to exercise and medication can be conclusively 
judged. 
Likewise, the conflicting evidence found for yoga compared to attention-control interventions 
or as an add-on to antidepressant medication might be explained by the very low sample 
size in the included RCTs, resulting in a too low power to detect positive effects. E.g., 
Uebelacker et al, 2015 would have need to include a total of 146 patients in their analysis to 
be able to detect the group differences found in their study with a power of 80%. Larger 
adequately powered studies are needed to assess whether yoga actually can reduce 
depression severity and/or increase remission rates in a clinically relevant way. 
In this review, electro-convulsive therapy was more effective than yoga in treating 
depression. Electro-convulsive therapy has been shown to be highly effective for treating 
major depression but to be to be far less tolerated than other interventions (Chen et al., 
2017). On the other hand, yoga has been shown to be very well tolerated by most 
participants (Cramer et al., 2016b). Given the very short-term intervention period in the 
included RCT (Janakiramaiah, 2000), the comparative long-term effectiveness and 
tolerability of yoga and electroconvulsive therapy needs to be investigated in future trials.   
Implications for clinical practice 
While this review found some evidence for positive effects beyond placebo and comparable 
effects compared to other evidence-based interventions (Gelenberg et al., 2010), the latter 
might mainly reflect a statistical artifact. Although prior systematic reviews suggest that yoga 
can be used as an adjunct intervention for otherwise healthy individuals with depressive 
symptoms (Cramer et al., 2013), its use in major depressive disorder is less clear. Given the 
small number of included patients, unclear methodology and – most importantly – the unclear 
risk-benefit ratio of the intervention, no recommendation for or against yoga as an alternative 
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or adjunct treatment for major depressive disorder can be made. The value of adding yoga to 
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Abbreviations: BAI: Beck Anxiety Inventory; BDI: Beck Depression Inventory; EPDS: Edinburgh Postnatal 
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Depression Scale; HAM-A: Hamilton Anxiety Rating Scale; HAM-D: Hamilton Rating Scale for Depression; MDD: 
Major Depressive Disorder; PHQ-9: Patient Health Questionnaire; QIDS: Quick Inventory of Depressive 
Symptoms-Clinician Rating. STAI: State-Trait Anxiety Inventory. 
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- Seven RCTs have investigated the effects of yoga in major depressive disorder. 
- There is some evidence of positive effects beyond placebo. 
- Yoga’s efficacy seems to be comparable to that of antidepressant medication. 













- 862 Scopus 
- 231 Cochrane 
 980 records excluded 
12 full-text articles excluded 
- 3 not randomized 
- 9 not all participants 
diagnosed with major 
depressive disorder 
997 records after duplicates 
removed 
17 full-text articles assessed 
for eligibility  
5 full-text articles included in 
qualitative synthesis  
1 additional records identified 
through other sources  
